Immunoglobulins, normal human, for intravascular [Power / Sample Size]

posted by Dr_Dan  – Germany, 2016-01-14 14:37 (3806 d 14:28 ago) – Posting: # 15827
Views: 6,381

Dear Yura
In a non-controlled (non-comparative) study no control/comparative group (in which subjects are given comparator drug) is used. Is it this what you mean? Pilot study for Proof-of-Concept to evaluate if some Parameters change?
This would be an exploratory study and no formal sample size calculation would be needed. If you want to assess treatment efficacy you need to compare to something (placebo, comparator drug or no treatment at all) and for such a (confirmatory) study you can make a sample size calculation based on the desired outcome (non-inferiority, equivalence or superiority). Please advise.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
146 visitors (0 registered, 146 guests [including 21 identified bots]).
Forum time: 06:06 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5